Compounds > gemcitabine
Page last updated: 2024-08-24

gemcitabine and Cancer of Nose

gemcitabine has been researched along with Cancer of Nose in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (75.00)24.3611
2020's2 (25.00)2.80

Authors

AuthorsStudies
Cai, H; Cao, X; Chen, M; Feng, J; Mao, Y; Wang, W; Wei, C; Yang, C; Zhang, L; Zhang, W; Zhang, Y; Zhou, D1
Liang, T; Liu, Z; Yang, C; Yang, D; Zheng, Y1
Chen, B; Dong, M; Fang, H; Gui, L; Li, Y; Lin, X; Liu, P; Qi, F; Qi, S; Song, Y; Wang, J; Wang, S; Yang, J; Yang, S; Zhou, S1
Chan, JK; Chan, KH; Kwong, YL; Pang, AW; So, JC1
Hu, YP; Jiang, W; Liu, CC; Wang, WD; Xia, ZJ; Zhang, J1
Dong, M; Gui, L; He, XH; Li, YX; Liu, P; Shi, YK; Wang, JJ; Wang, WH; Yang, JL; Yang, S; Zhang, CG; Zhou, SY1
Cao, J; Fan, S; Jia, S; Li, S; Li, Z; Nan, F; Su, L; Wang, J; Xue, H; Zhang, C; Zhang, L; Zhang, M1
Ahn, HK; Hwang, DW; Kim, SJ; Kim, WS; Ko, YH; Lim, ST; Tang, T1

Trials

1 trial(s) available for gemcitabine and Cancer of Nose

ArticleYear
Combined gemcitabine, cisplatin, dexamethasone, methotrexate, and pegaspargase (GDP-ML) for patients with newly diagnosed extranodal natural killer/T cell lymphoma, nasal type: a single arm, single center, prospective phase 2 study.
    Annals of hematology, 2020, Volume: 99, Issue:12

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cisplatin; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Middle Aged; Nose Neoplasms; Polyethylene Glycols; Prospective Studies; Survival Rate; Young Adult

2020

Other Studies

7 other study(ies) available for gemcitabine and Cancer of Nose

ArticleYear
Combined use of DDGP and IMRT has a good effect on extranodal natural killer/T-cell lymphoma, nasal type.
    Hematological oncology, 2020, Volume: 38, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Chemoradiotherapy; Child; Cisplatin; Deoxycytidine; Dexamethasone; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Nose Neoplasms; Polyethylene Glycols; Prognosis; Retrospective Studies; Survival Rate; Young Adult

2020
Upfront radiation is essential for high-risk early-stage extranodal NK/T-cell lymphoma, nasal type: comparison of two sequential treatment modalities combining radiotherapy and GDP (gemcitabine, dexamethasone, and cisplatin) in the modern era.
    Leukemia & lymphoma, 2019, Volume: 60, Issue:11

    Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Cisplatin; Deoxycytidine; Dexamethasone; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Nose Neoplasms; Prognosis; Radiotherapy, Intensity-Modulated; Retrospective Studies; Survival Rate; Young Adult

2019
Diagnosis of brainstem involvement in NK/T cell lymphoma.
    Annals of hematology, 2014, Volume: 93, Issue:8

    Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Brain Stem; Cerebrospinal Fluid; Cisplatin; Deoxycytidine; Dexamethasone; DNA, Viral; Etoposide; Gemcitabine; Herpesvirus 4, Human; Humans; Ifosfamide; Lymphoma, Extranodal NK-T-Cell; Male; Methotrexate; Neoplastic Stem Cells; Nose Neoplasms; Ophthalmoplegia; Trigeminal Nerve Diseases; Viral Load

2014
Ki-67 Can Predict the Response to the Gemcitabine, Oxaliplatin And L-asparaginase Regimen (GELOX) and Prognosis in Patients with Nasal Natural Killer/T-cell Lymphoma.
    Asian Pacific journal of cancer prevention : APJCP, 2015, Volume: 16, Issue:11

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Biomarkers, Tumor; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Immunoenzyme Techniques; Ki-67 Antigen; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Staging; Nose Neoplasms; Organoplatinum Compounds; Oxaliplatin; Prognosis; Retrospective Studies; Survival Rate; Young Adult

2015
GDP (Gemcitabine, Dexamethasone, and Cisplatin) Is Highly Effective and Well-Tolerated for Newly Diagnosed Stage IV and Relapsed/Refractory Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type.
    Medicine, 2016, Volume: 95, Issue:6

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Dexamethasone; Female; Gemcitabine; Humans; Lymphoma, T-Cell; Male; Middle Aged; Natural Killer T-Cells; Neoplasm Recurrence, Local; Neoplasm Staging; Nose Neoplasms; Retrospective Studies; Treatment Outcome

2016
The DDGP (cisplatin, dexamethasone, gemcitabine, and pegaspargase) regimen for treatment of extranodal natural killer (NK)/T-cell lymphoma, nasal type.
    Oncotarget, 2016, Sep-06, Volume: 7, Issue:36

    Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Cisplatin; Deoxycytidine; Dexamethasone; Disease-Free Survival; Female; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Natural Killer T-Cells; Nose Neoplasms; Polyethylene Glycols; Prognosis; Retrospective Studies; Treatment Outcome; Young Adult

2016
Gemcitabine alone and/or containing chemotherapy is efficient in refractory or relapsed NK/T-cell lymphoma.
    Investigational new drugs, 2013, Volume: 31, Issue:2

    Topics: Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Follow-Up Studies; Gemcitabine; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Nose Neoplasms; Prognosis; Remission Induction; Retrospective Studies; Salvage Therapy; Skin Neoplasms; Survival Rate

2013